MBX Biosciences, Inc.
MBX
$8.70
$0.070.81%
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 26.66% | -0.13% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 17.73% | 25.12% | |||
| Operating Income | -17.73% | -25.12% | |||
| Income Before Tax | -14.41% | -28.53% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -14.41% | -28.53% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -14.41% | -28.53% | |||
| EBIT | -17.73% | -25.12% | |||
| EBITDA | -17.73% | -25.09% | |||
| EPS Basic | -165.26% | -22.99% | |||
| Normalized Basic EPS | -165.23% | -23.00% | |||
| EPS Diluted | -165.26% | -22.99% | |||
| Normalized Diluted EPS | -165.23% | -23.00% | |||
| Average Basic Shares Outstanding | -56.87% | 4.50% | |||
| Average Diluted Shares Outstanding | -56.87% | 4.50% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
